Inicio › Cáncer de pulmón de células no pequeñas › Illinois › Cicero
Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Cicero, IL
24 estudios para Cáncer de pulmón de células no pequeñas buscan participantes en centros de Cicero y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
ReclutandoFase 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · A 10 mi de distancia
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- Edward Hines Jr VA Hospital, Hines · A 4 mi de distancia
- Advocate Christ Medical Center, Oak Lawn · A 9 mi de distancia
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ReclutandoFase 3
- Northwestern Medicine Oak Brook, Oak Brook · A 9 mi de distancia
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ReclutandoFase 3
- Hope and Healing Cancer Services, Hinsdale · A 10 mi de distancia
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
ReclutandoFase 3
- Advocate Christ Medical Center, Oak Lawn · A 9 mi de distancia
- Hope and Healing Cancer Services, Hinsdale · A 10 mi de distancia
- Endeavor Health, Elmhurst · A 10 mi de distancia
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
ReclutandoFase 2
- Hope and Healing Clinical Research, Hinsdale · A 10 mi de distancia
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
ReclutandoFase 3
- Research Site, Hinsdale · A 10 mi de distancia
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
ReclutandoFase 3
- Affiliated Oncologists, LLC, Chicago Ridge · A 10 mi de distancia
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
ReclutandoFase 3
- Research Site, Hinsdale · A 10 mi de distancia
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
ReclutandoFase 2/3
- Loyola University Medical Center, Maywood · A 5 mi de distancia
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
ReclutandoFase 3
- Hope and Healing Cancer Services, Hinsdale · A 10 mi de distancia
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
ReclutandoFase 3
- Affiliated Oncologists, LLC, Chicago Ridge · A 10 mi de distancia
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
ReclutandoFase 3
- Research Site, Hinsdale · A 10 mi de distancia
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
ReclutandoFase 3
- Research Site, Hinsdale · A 10 mi de distancia
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
ReclutandoFase 3
- Northwestern Medicine Oak Brook, Oak Brook · A 9 mi de distancia
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
ReclutandoFase 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · A 10 mi de distancia
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutandoFase 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · A 3 mi de distancia
- Edward Hines Jr VA Hospital, Hines · A 4 mi de distancia
- Loyola University Medical Center, Maywood · A 5 mi de distancia
- y 2 más
MYLUNG Consortium Part 3: Observational Study
ReclutandoEstudio observacional
- Affiliated Oncologists, LLC, Chicago Ridge · A 10 mi de distancia
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- Edward Hines Jr VA Hospital, Hines · A 4 mi de distancia
- Loyola University Medical Center, Maywood · A 5 mi de distancia
- Northwestern Medicine Oak Brook, Oak Brook · A 9 mi de distancia
- y 3 más
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2/3
- Loyola University Medical Center, Maywood · A 5 mi de distancia
- Northwestern Medicine Oak Brook, Oak Brook · A 9 mi de distancia
- Advocate Christ Medical Center, Oak Lawn · A 9 mi de distancia
- y 2 más
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- Edward Hines Jr VA Hospital, Hines · A 4 mi de distancia
- Loyola University Medical Center, Maywood · A 5 mi de distancia
- Northwestern Medicine Oak Brook, Oak Brook · A 9 mi de distancia
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- Advocate Christ Medical Center, Oak Lawn · A 9 mi de distancia
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · A 9 mi de distancia
- Advocate High Tech Medical Park, Palos Heights · A 12 mi de distancia
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Reclutando
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · A 4 mi de distancia
GEMINI-NSCLC: NSCLC Biomarker Study
ReclutandoEstudio observacional
- Hope and Healing Cancer Services, Hinsdale · A 10 mi de distancia
Ensayos de Cáncer de pulmón de células no pequeñas en otras ciudades
- Houston, TX145 estudios
- New York City, NY121 estudios
- Arlington, VA104 estudios
- Nashville, TN97 estudios
- Boston, MA90 estudios
- Los Angeles, CA87 estudios
- St. Louis, MO73 estudios
- Chicago, IL61 estudios
- Baltimore, MD60 estudios
- San Antonio, TX59 estudios
- Columbus, OH57 estudios
- Washington, DC55 estudios
Otros estudios en Cicero
- Cáncer de pulmón17 estudios
- Cáncer de próstata14 estudios
- Cáncer (todos los tipos)13 estudios
- Cáncer de seno11 estudios
- Leucemia mielógena aguda11 estudios
- Cáncer del colon y del recto10 estudios
- Cáncer de vejiga8 estudios
- Melanoma7 estudios
- Enfermedad cardiovascular7 estudios
- Cáncer metastásico7 estudios
- Mieloma múltiple6 estudios
- Linfoma de Burkitt6 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.